PRVA
Price
$27.36
Change
+$0.48 (+1.79%)
Updated
Jul 2 closing price
Capitalization
3.45B
31 days until earnings call
Intraday BUY SELL Signals
WAY
Price
$23.45
Change
+$3.54 (+17.79%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
4.5B
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRVA vs WAY

PRVA vs WAY Comparison Chart in %
View a ticker or compare two or three
VS
PRVA vs. WAY commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRVA is a Buy and WAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2026
Stock price -- (PRVA: $27.36 vs. WAY: $23.46)
Brand notoriety: PRVA and WAY are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: PRVA: 40% vs. WAY: 138%
Market capitalization -- PRVA: $3.45B vs. WAY: $4.5B
PRVA [@Services to the Health Industry] is valued at $3.45B. WAY’s [@Services to the Health Industry] market capitalization is $4.5B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $31.31B to $0. The average market capitalization across the [@Services to the Health Industry] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRVA’s FA Score shows that 0 FA rating(s) are green whileWAY’s FA Score has 0 green FA rating(s).

  • PRVA’s FA Score: 0 green, 5 red.
  • WAY’s FA Score: 0 green, 5 red.
According to our system of comparison, PRVA is a better buy in the long-term than WAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRVA’s TA Score shows that 7 TA indicator(s) are bullish while WAY’s TA Score has 4 bullish TA indicator(s).

  • PRVA’s TA Score: 7 bullish, 3 bearish.
  • WAY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PRVA is a better buy in the short-term than WAY.

Price Growth

PRVA (@Services to the Health Industry) experienced а +11.54% price change this week, while WAY (@Services to the Health Industry) price change was +23.73% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +5.34%. For the same industry, the average monthly price growth was +1.27%, and the average quarterly price growth was -3.64%.

Reported Earning Dates

PRVA is expected to report earnings on Aug 06, 2026.

WAY is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Services to the Health Industry (+5.34% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WAY($4.5B) has a higher market cap than PRVA($3.45B). PRVA has higher P/E ratio than WAY: PRVA (138.18) vs WAY (25.84). PRVA YTD gains are higher at: 15.394 vs. WAY (-28.366). WAY has higher annual earnings (EBITDA): 413M vs. PRVA (47.7M). PRVA has more cash in the bank: 420M vs. WAY (159M). PRVA has less debt than WAY: PRVA (9.02M) vs WAY (1.49B). PRVA has higher revenues than WAY: PRVA (2.25B) vs WAY (1.16B).
PRVAWAYPRVA / WAY
Capitalization3.45B4.5B77%
EBITDA47.7M413M12%
Gain YTD15.394-28.366-54%
P/E Ratio138.1825.84535%
Revenue2.25B1.16B194%
Total Cash420M159M264%
Total Debt9.02M1.49B1%
TECHNICAL ANALYSIS
Technical Analysis
PRVAWAY
RSI
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
62%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
PRVA
Daily Signal:
Gain/Loss:
WAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KCE153.352.71
+1.80%
State Street® SPDR® S&P® Cap Mkts ETF
TMFE29.980.26
+0.86%
Motley Fool Capital Efficiency 100 ETF
HELO67.59N/A
N/A
JPMorgan Hedged Equity Ldrd Ovrly ETF
BLSG1.70N/A
N/A
Leverage Shares 2X Long BLSH Daily ETF
MSTZ11.11-2.13
-16.09%
T-REX 2X Inverse MSTR Daily Target ETF

PRVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRVA has been loosely correlated with RIOT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRVA jumps, then RIOT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRVA
1D Price
Change %
PRVA100%
+1.79%
RIOT - PRVA
46%
Loosely correlated
-7.72%
EVCM - PRVA
45%
Loosely correlated
-6.29%
EVTC - PRVA
45%
Loosely correlated
+2.00%
SPT - PRVA
45%
Loosely correlated
+1.13%
QLYS - PRVA
45%
Loosely correlated
+3.26%
More

WAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, WAY has been loosely correlated with HQY. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if WAY jumps, then HQY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WAY
1D Price
Change %
WAY100%
+9.47%
HQY - WAY
40%
Loosely correlated
+3.27%
PHR - WAY
39%
Loosely correlated
+2.05%
TDOC - WAY
35%
Loosely correlated
+1.10%
HSTM - WAY
31%
Poorly correlated
+0.46%
PRVA - WAY
30%
Poorly correlated
+1.79%
More